ASX:XF1 Xref (XF1) Stock Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free XF1 Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume854,858 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield6.00%Price TargetN/A Stock AnalysisStock Analysis Get Xref alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Xref Stock (ASX:XF1)Xref Limited engages in the development of human resources technology that automates the candidate reference process for employers in Australia, Canada, the United Kingdom, New Zealand, and the United States. It operates through three segments: Candidate Referencing, ID Verification, Engagement Surveys. The company offers Xref, an automated reference checking software for talent acquisition, recruitment process outsourcing, staffing and recruitment firms, and people and culture. It serves not-for-profit, health and aged care, hospitality, construction, and retail industries, as well as government sector. The company is headquartered in Macquarie Park, Australia.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> XF1 Stock News HeadlinesAugust 30, 2023 | finance.yahoo.comXref Full Year 2023 Earnings: AU$0.018 loss per share (vs AU$0.004 profit in FY 2022)April 18, 2023 | finance.yahoo.comXref Limited's (ASX:XF1) Subdued P/S Might Signal An OpportunityApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 30, 2023 | ca.finance.yahoo.comXref Limited (XF1.AX)March 2, 2023 | msn.comXref says people-focused data is key to building a corporate memoryJanuary 31, 2023 | finance.yahoo.comShould You Be Impressed By Xref Limited's (ASX:XF1) ROE?November 22, 2022 | afr.comXref LimitedNovember 22, 2022 | finance.yahoo.comXref (ASX:XF1) acquires employee engagement platform, Voice Project, to compete with incumbent unicornsApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.November 22, 2022 | finance.yahoo.comShareholders May Not Be So Generous With Xref Limited's (ASX:XF1) CEO Compensation And Here's WhyNovember 14, 2022 | finance.yahoo.comXref (ASX:XF1) launches 'Trust Marketplace' to help employers rapidly & safely recruit in global staffing crisisOctober 10, 2022 | finance.yahoo.comXref goes full "hire to retire" with launch of new Enterprise platformSeptember 14, 2022 | proactiveinvestors.com.auCV Check FY22 results in-line, forecasts intact: RaaS AdvisoryAugust 28, 2022 | reuters.comXF1.AX - Xref Ltd | Stock Price & Latest News | ReutersAugust 25, 2022 | yahoo.comOz aide mocks Fetterman’s stroke in escalation of crudité tiffJuly 5, 2022 | fool.com.auXref share price tumbles 19% despite record result for FY22June 2, 2022 | finance.yahoo.comXref (ASX:XF1) shareholders have earned a 74% return over the last yearApril 18, 2022 | finance.yahoo.comDoes Xref (ASX:XF1) Have A Healthy Balance Sheet?February 27, 2022 | msn.comXref (ASX:XF1) share price slides 5% despite surge in gross salesJanuary 27, 2022 | msn.comASX tech shares are plummeting today but this one just hit a 9-year highJanuary 23, 2022 | yahoo.comApple Watch Series 7 & SE have deep discounts you won’t believeJanuary 19, 2022 | finance.yahoo.comEstimating The Fair Value Of Xref Limited (ASX:XF1)November 28, 2021 | msn.comASX Tech Stocks: HR player Xref adds social media scanning partner to its candidate vetting platformOctober 20, 2021 | finance.yahoo.comInvesting in Xref (ASX:XF1) a year ago would have delivered you a 236% gainOctober 8, 2021 | fool.com.auWhy has the IntelliHR (ASX: IHR) share price jumped 8% on Thursday?October 6, 2021 | msn.comXref (ASX:XF1) share price surges 5% on achieving 126% sales growthSee More Headlines Receive XF1 Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Xref and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2019Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorComputer and Technology Industry Software - Application Sub-IndustryN/A Current SymbolASX:XF1 CUSIPN/A CIKN/A Webwww.xref.com Phone61 2 8244 3099FaxN/AEmployees114Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,980,000.00 Net Margins-28.86% Pretax MarginN/A Return on Equity-529.17% Return on Assets-16.32% Debt Debt-to-Equity Ratio373.14 Current Ratio0.32 Quick Ratio1.05 Sales & Book Value Annual Sales$20.72 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow6.25 Book ValueA($0.02) per share Price / BookN/AMiscellaneous Outstanding Shares189,080,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.58 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Lee-Martin John SeymourFounder, MD, CEO & Executive DirectorMr. James Solomons B.Com.CTA, F.C.A., CFO & COOMs. Sharon BlessonCTO and Director of Delivery & OperationsMr. Robert John Waring BEcCA, FAICD, FCIS, FFin, Company SecretaryMs. Melanie SeymourCompliance ManagerTracy MurdochGeneral CounselMs. Sarah MulvennaGroup GM of RevenueMore ExecutivesKey Competitors01 Communique LaboratoryOTCMKTS:OCQLF1mage SoftwareCNSX:ISOL8commonASX:8CO9 Spokes InternationalASX:9SPaccesso Technology GroupOTCMKTS:LOQPFView All Competitors XF1 Stock Analysis - Frequently Asked Questions How were Xref's earnings last quarter? Xref Limited (ASX:XF1) released its earnings results on Thursday, February, 28th. The company reported ($0.03) earnings per share (EPS) for the quarter. Xref had a negative net margin of 28.86% and a negative trailing twelve-month return on equity of 529.17%. What other stocks do shareholders of Xref own? Based on aggregate information from My MarketBeat watchlists, some companies that other Xref investors own include Macquarie Group (MQG), Magellan Financial Group (MFG), Medlab Clinical (MDC), FBR (FBR), Embark Early Education (EVO), Dacian Gold (DCN), Constellation Technologies (CT1), Afterpay (APT) and Alkane Resources (ALK). This page (ASX:XF1) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe World's First "$20 Trillion Drug?"Behind the MarketsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xref Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
